What We're Reading: Page 213
Industry reads hand-picked by our editors
Dec 13, 2019
-
C&EN
So you want to make a personalized drug? This company has got your back
-
Bloomberg
Miracle Cancer Drugs Are Making Big Pharma Billions. Others Are Getting Left Behind
-
Endpoints News
Bristol-Myers' strategy, BD chief Paul Biondi exited the company — just ahead of the $74B Celgene deal close
-
Kaiser Health News
In The Fight For Money For The Opioid Crisis, Will The Youngest Victims Be Left Out?